|
|||||
|
|

Mortgage insurance provider Enact Holdings (NASDAQ:ACT) missed Wall Street’s revenue expectations in Q2 CY2025 as sales rose 2% year on year to $304.9 million. Its non-GAAP profit of $1.15 per share was 3.8% above analysts’ consensus estimates.
Is now the time to buy ACT? Find out in our full research report (it’s free).
Enact Holdings' second quarter results were shaped by a mix of disciplined underwriting and continued credit strength, despite revenue landing just below Wall Street's expectations. Management highlighted robust new insurance written and resilient borrower credit metrics, noting that embedded equity and effective loss mitigation contributed to a significant reserve release. CEO Rohit Gupta pointed to the company’s ability to “navigate a complex macroeconomic environment,” emphasizing that favorable delinquency trends and strong persistency helped offset ongoing industry headwinds, including affordability challenges and regional home price softness.
Looking forward, management’s outlook centers on maintaining strong credit performance and capital flexibility in the face of macroeconomic uncertainty and potential regulatory changes. CEO Rohit Gupta underlined the importance of demographic tailwinds and prudent risk management, stating, “Our strong balance sheet, disciplined risk management and thoughtful approach to capital deployment provide meaningful flexibility as we execute our strategy.” The company’s focus remains on adapting to any shifts in housing policy, leveraging a robust capital position, and executing on new business initiatives to drive long-term growth.
Management attributed quarterly performance to constructive pricing, expense discipline, and robust credit trends, while acknowledging the impact of ongoing macroeconomic and regulatory uncertainty.
Enact’s guidance is grounded in expectations for sustained credit quality, cautious capital deployment, and adaptability to evolving housing and regulatory trends.
In the coming quarters, the StockStory team will be watching (1) trends in new insurance written and persistency as the housing market adapts to affordability pressures, (2) any shifts in delinquency rates or claims as regional home prices fluctuate, and (3) the impact of regulatory changes or new GSE guidelines on Enact’s capital allocation strategy. Expansion of the Enact Re platform and execution on capital returns will also be key areas of focus.
Enact Holdings currently trades at $37.72, up from $34.39 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-22 | |
| Oct-09 | |
| Oct-09 | |
| Oct-03 | |
| Oct-02 | |
| Oct-01 | |
| Sep-25 | |
| Sep-25 | |
| Sep-18 | |
| Sep-01 | |
| Aug-28 | |
| Aug-19 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite